Conclusion
myocardial infarction, diabetes or impaired glucose tolerance
HEART FAILURE, MYOCARDIAL INFARCTION, UNSTABLE ANGINA, INSULIN SENSITIVITY
Empagliflozin improved insulin sensitivity indexes in patients with a recent myocardial infarction or unstable angina, without heart failure, and with newly detected, drug naïve diabetes or impaired glucose tolerance.